Your browser doesn't support javascript.
loading
18F-fluorodeoxyglucose PET/Computed Tomography: Head and Neck Salivary Gland Tumors.
Broski, Stephen M; Johnson, Derek R; Packard, Annie T; Hunt, Christopher H.
Afiliação
  • Broski SM; Department of Radiology, Mayo Clinic, Rochester, MN, USA. Electronic address: Broski.stephen@mayo.edu.
  • Johnson DR; Department of Radiology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Packard AT; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Hunt CH; Department of Radiology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
PET Clin ; 17(2): 249-263, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35232668
ABSTRACT
Salivary gland tumors (SGTs) are a heterogeneous group of neoplasms arising from the 3 pairs of major salivary glands (parotid, submandibular, and sublingual) or numerous minor salivary glands located throughout the oral cavity. This review discusses the role of PET/computed tomography (CT) in evaluation of SGTs, including staging, restaging, prognostication, and response assessment. 18F-fluorodeoxyglucose (FDG) PET/CT is useful for staging and restaging malignant SGTs and offers important prognostic information in these patients. It is less useful for differentiating benign and malignant SGTs. Non-FDG PET radiotracers, perineural spread, parotid incidentalomas, and interpretative pitfalls are discussed as well.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Salivares / Fluordesoxiglucose F18 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Salivares / Fluordesoxiglucose F18 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article